a Faculty of Medicine and Life Sciences , University of Tampere , Tampere , Finland.
b Faculty of Social Sciences , University of Tampere , Tampere , Finland.
Acta Oncol. 2019 Jul;58(7):990-996. doi: 10.1080/0284186X.2019.1603396. Epub 2019 Apr 15.
Several studies have reported increased incidence trends of malignant gliomas in the late 1900s with a plateau in the 2000s, but also some recent increases have been reported. The purpose of our study was to analyze incidence trends of malignant gliomas in Finland by morphology and tumor location. Data on 4730 malignant glioma patients were obtained from case notifications to the nationwide, population-based Finnish Cancer Registry (FCR), and less detailed data on 3590 patients up to 2016. Age-standardized incidence rates (ASR) and average annual percent changes (APCs) in the incidence rates were calculated by histological subtype and tumor location. The incidence rate of gliomas was 7.7/100,000 in 1990-2006 and 7.3 in 2007-2016. The incidence of all gliomas combined was stable during both study periods, with no departure from linearity. In an analysis by age group, increasing incidence was found only for ages 80 years and older (1990-2006). During both study periods, incidence rates were increasing in glioblastoma and decreasing in unspecified brain tumors. In 1990-2006, rates were also increasing for anaplastic oligodendroglioma, oligoastrocytoma and unspecified malignant glioma, while decreasing for astrocytoma. As for tumor location, incidence in 1990-2006 was increasing for frontal lobe and brainstem tumors, as well as those with an unspecified location, but decreasing for the parietal lobes, cerebrum and ventricles. No increasing incidence trend was observed for malignant gliomas overall. An increasing incidence trend of malignant gliomas was found in the oldest age group during 1990-2006.
几项研究报告称,20 世纪 90 年代末恶性神经胶质瘤的发病率呈上升趋势,并在 21 世纪 00 年代达到高峰,但最近也有一些报告称发病率有所上升。本研究的目的是通过形态和肿瘤位置分析芬兰恶性神经胶质瘤的发病趋势。 从全国性的基于人群的芬兰癌症登记处(FCR)获得了 4730 名恶性神经胶质瘤患者的病例通知数据,截至 2016 年,还有 3590 名患者的详细数据。根据组织学亚型和肿瘤位置计算了年龄标准化发病率(ASR)和发病率的平均年变化百分比(APC)。 1990-2006 年,胶质瘤的发病率为 7.7/100,000,2007-2016 年为 7.3/100,000。在两个研究期间,所有胶质瘤的综合发病率保持稳定,没有线性偏离。在按年龄组进行的分析中,仅发现 80 岁及以上年龄组的发病率在增加(1990-2006 年)。在两个研究期间,胶质母细胞瘤的发病率呈上升趋势,未指定的脑肿瘤发病率呈下降趋势。1990-2006 年,间变性少突胶质细胞瘤、少突星形细胞瘤和未指定的恶性神经胶质瘤的发病率也呈上升趋势,而星形细胞瘤的发病率则呈下降趋势。至于肿瘤位置,1990-2006 年,额叶和脑干肿瘤以及未指定位置的肿瘤发病率呈上升趋势,而顶叶、大脑和脑室的肿瘤发病率呈下降趋势。 总体而言,恶性神经胶质瘤没有观察到发病率上升的趋势。在 1990-2006 年期间,最年长的年龄组恶性神经胶质瘤的发病率呈上升趋势。